ROUTINE HEMATOLOGICAL PROFILE OF TYPE 2 DIABETES MELLITUS PATIENTS AT BANTEN PROVINCIAL GENERAL HOSPITAL
Keywords:
Type 2 Diabetes Mellitus; Hemoglobin; Leukocytes; Hematocrit; PlateletsAbstract
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia resulting from impaired insulin secretion, insulin resistance, or a combination of both. Prolonged hyperglycemia can induce changes in hematological parameters through mechanisms involving chronic inflammation, oxidative stress, and vascular endothelial damage. This study aimed to assess the routine hematological profile of T2DM patients at the Banten Provincial General Hospital (RSUD). An observational descriptive study with a cross-sectional design was employed. The study sample consisted of 30 T2DM patients selected using purposive sampling. Data were obtained through routine hematological analysis using a hematology analyzer, while respondent characteristics were gathered via questionnaires and medical records. The results showed that the majority of respondents were aged 56–65 years (40.0%), female (56.7%), and had been diagnosed with T2DM for 1–5 years (66.7%). Routine hematological examinations revealed that most respondents had hemoglobin levels, hematocrit, leukocyte counts, and platelet counts within the normal range. However, elevated or decreased values in these hematological parameters were observed in a small proportion of respondents. It is concluded that most T2DM patients at the Banten Provincial General Hospital exhibit routine hematological profiles within normal limits. Nevertheless, alterations in certain hematological parameters were still observed, suggesting that routine hematological examination could serve as a useful supportive test for monitoring the condition of T2DM patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Proceeding of Banten Internasional Conference on Health Advancement and Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
